当前位置:首页 - 行情中心 - 恩华药业(002262) - 财务分析 - 资产负债表

恩华药业

(002262)

  

流通市值:185.26亿  总市值:213.50亿
流通股本:8.82亿   总股本:10.16亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金2,082,237,101.861,416,389,329.181,546,117,761.581,429,199,628.36
应收票据及应收账款1,686,308,379.41,490,227,895.851,283,875,284.131,274,489,503.06
应收账款1,686,308,379.41,490,227,895.851,283,875,284.131,274,489,503.06
应收款项融资31,759,290.556,185,137.6417,919,106.2918,172,326.07
预付款项43,540,691.4557,839,165.8241,286,088.8449,286,343.39
其他应收款合计55,434,569.7321,922,110.7466,443,553.8260,040,200.54
存货665,411,808.07661,393,912.49660,874,882.77555,095,000.33
其他流动资产21,801,816.6132,594,508.7211,067,46411,744,241.58
流动资产平衡项目0000
流动资产合计6,498,493,657.676,059,552,060.445,927,584,141.435,490,037,243.33
非流动资产:
长期股权投资98,947,043.1397,317,706.973,879,485.8473,892,069.06
其他权益工具投资27,991,040.7127,991,040.7134,223,290.9434,223,290.94
投资性房地产51,470,176.452,035,702.8352,601,229.2649,497,904.65
固定资产1,212,801,665.131,237,823,397.451,140,698,579.691,144,606,808.74
在建工程304,120,978.49309,380,730.34287,792,996.43289,162,691.46
使用权资产55,540,416.8161,636,729.5554,899,166.5158,012,223.35
无形资产227,516,683.06232,089,680.26230,347,878.66231,224,430.2
开发支出176,557,284.48162,316,071.3115,355,689.3665,609,174.1
长期待摊费用91,922,870.84101,298,807.385,708,013.6797,742,423.18
递延所得税资产57,913,935.3255,394,490.3645,192,453.2748,579,522.66
其他非流动资产65,747,644.8343,169,238.5180,625,833.0759,802,560.74
非流动资产平衡项目0000
非流动资产合计2,370,529,739.22,380,453,595.512,201,324,616.72,152,353,099.08
资产平衡项目0000
资产总计8,869,023,396.878,440,005,655.958,128,908,758.137,642,390,342.41
流动负债:
短期借款10,000,00015,000,00065,000,00085,000,000
应付票据及应付账款614,597,175.97568,352,386.42432,003,268.66344,453,211.89
其中:应付票据309,487,426.84280,524,622.3180,232,952.5382,144,965.25
应付账款305,109,749.13287,827,764.12251,770,316.13262,308,246.64
合同负债26,271,181.9541,528,172.4431,727,482.8235,079,931.55
应付职工薪酬-3,426,710--
应交税费191,479,890.44179,113,942.19177,096,479.21158,085,613.89
其他应付款合计315,333,003.66234,783,726.4199,719,576.53180,910,045.2
一年内到期的非流动负债21,491,082.2520,176,705.4220,647,116.2821,381,065.17
其他流动负债2,334,142.363,858,988.563,092,611.983,815,865.32
流动负债平衡项目0000
流动负债合计1,181,506,476.631,066,240,631.43929,286,535.48828,725,733.02
非流动负债:
长期借款230,000230,000230,000230,000
租赁负债28,497,713.9133,865,907.1928,364,191.132,370,221.15
预计负债24,635,621.3424,635,621.3412,946,109.5312,946,109.53
递延收益41,406,697.841,406,697.853,865,250.2753,865,250.27
递延所得税负债-111,020.41--
非流动负债平衡项目0000
非流动负债合计94,770,033.05100,249,246.7495,405,550.999,411,580.95
负债平衡项目0000
负债合计1,276,276,509.681,166,489,878.171,024,692,086.38928,137,313.97
所有者权益(或股东权益):
实收资本(或股本)1,016,176,7921,016,176,7921,016,176,7921,007,588,092
资本公积262,769,664.68244,178,189.68193,253,035.31102,985,798.31
减:库存股98,855,93798,855,93798,855,937-
其他综合收益873,251.82873,251.826,754,407.196,754,407.19
盈余公积508,088,396508,088,396503,794,046503,794,046
未分配利润5,930,566,772.915,629,861,031.985,510,698,077.615,119,511,222.86
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计7,619,618,940.417,300,321,724.487,131,820,421.116,740,633,566.36
少数股东权益-26,872,053.22-26,805,946.7-27,603,749.36-26,380,537.92
股东权益平衡项目0000
股东权益合计7,592,746,887.197,273,515,777.787,104,216,671.756,714,253,028.44
负债和股东权益合计8,869,023,396.878,440,005,655.958,128,908,758.137,642,390,342.41
公告日期2025-04-192025-03-292024-10-262024-07-31
审计意见(境内)标准无保留意见
TOP↑